STOCK TITAN

Fonar Corporation (FONR) Financials

FONR
Trailing 12 months to March 31, 2026
Revenue $105.3M +2.3% YoY
Net Income $6.7M -20.7% YoY
Free Cash Flow $4.6M -43.3% YoY
Operating Cash Flow $7.7M -34.2% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Mar 31, 2026 Reported Currency USD FYE June

Newest figures come from the 10-Q for Q3 FY2026, filed May 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FONR SEC filings page.

Fonar Corporation (FONR) reported $105.3M in revenue over the twelve months to Mar 31, 2026, up 2.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI FONR FY2025

Fonar’s dominant mechanic is internally funded growth whose cash conversion weakened as reinvestment and shareholder distributions absorbed more operating cash.

Revenue increased in FY2025 while net margin slipped to 8.0%, indicating incremental sales were less profitable. Operating cash flow fell to $11.3M while free cash flow fell to $7.5M, showing that earnings translated into less discretionary cash after investment.

The business has grown revenue for four consecutive years, but operating profitability has not scaled smoothly: operating margin moved from 11.3% in FY2023 to 4.4% in FY2024, pointing to cost or mix sensitivity rather than a simple fixed-cost absorption story.

Capital spending jumped from $790K in FY2024 to $3.8M in FY2025, leaving free-cash-flow margin at 7.2%. Even so, the high current ratio and broadly stable liabilities indicate substantial short-term liquidity while financing outflows also included share buybacks.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 63 / 100
Financial Health Score 63/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Fonar Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
59
Growth
41

Fonar Corporation's revenue grew a modest 1.4% year-over-year to $104.4M. This slow but positive growth earns a score of 41/100.

Leverage
68

Fonar Corporation carries a low D/E ratio of 0.33, meaning only $0.33 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 68/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
97

With a current ratio of 8.45, Fonar Corporation holds $8.45 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 97/100.

Cash Flow
64

Fonar Corporation has a free cash flow margin of 7.2%, earning a moderate score of 64/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
49

Fonar Corporation's ROE of 4.8% shows moderate profitability relative to equity, earning a score of 49/100. This is down from 6.4% the prior year.

Piotroski F-Score Partial
5/6

Fonar Corporation passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.35x

For every $1 of reported earnings, Fonar Corporation generates $1.35 in operating cash flow ($11.3M OCF vs $8.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$26.5M
YoY-2.6%
QoQ+3.6%
5Y CAGR+2.8%
10Y CAGR+47.4%

Fonar Corporation generated $26.5M in revenue in Q3 2026. This represents a decrease of 2.6% from the same quarter a year earlier. Against the prior quarter it is up 3.6%.

Net Income
$1.6M
YoY-34.5%
QoQ-20.2%
5Y CAGR-15.8%
10Y CAGR-5.9%

Fonar Corporation reported $1.6M in net income in Q3 2026. This represents a decrease of 34.5% from the same quarter a year earlier. Against the prior quarter it is down 20.2%.

EBITDA

Not reported for Q3 2026.

EPS (Diluted)

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow
$1.4M
YoY-44.7%
QoQ+720.7%
5Y CAGR-12.8%
10Y CAGR-4.6%

Fonar Corporation generated $1.4M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 44.7% from the same quarter a year earlier. Against the prior quarter it is up 720.7%.

Cash & Debt
$53.6M
YoY-1.1%
QoQ+1.3%
5Y CAGR+5.6%
10Y CAGR+15.1%

Fonar Corporation held $53.6M in cash as of Q3 2026; long-term debt is not reported for that period.

Dividends Per Share

Not reported for Q3 2026.

Shares Outstanding

Not reported for Q3 2026.

Margins & Returns

Net Margin
6.2%
YoY-3.0pp
QoQ-1.9pp
5Y change-10.6pp

Fonar Corporation's net profit margin was 6.2% in Q3 2026, showing the share of revenue converted to profit. This is down 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.9 percentage points.

Return on Equity
0.9%
YoY-0.5pp
QoQ-0.2pp
5Y change-1.9pp

Fonar Corporation's ROE was 0.9% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Capital Allocation

R&D Spending
$424K
YoY-3.9%
QoQ-6.8%
5Y CAGR+0.2%
10Y CAGR+0.7%

Fonar Corporation invested $424K in research and development in Q3 2026. This represents a decrease of 3.9% from the same quarter a year earlier. Against the prior quarter it is down 6.8%.

Capital Expenditures
$171K
YoY-71.4%
QoQ-57.0%
5Y CAGR-26.5%
10Y CAGR+3.2%

Fonar Corporation invested $171K in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 71.4% from the same quarter a year earlier. Against the prior quarter it is down 57.0%.

Share Buybacks

Not reported for Q3 2026.

FONR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FONR quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$26.5M-2.6%$25.5M+2.4%$26.0M+4.3%$27.3M+5.1%$27.2M+5.6%$24.9M-1.7%$25.0M-3.4%$25.9M+0.6%
R&D Expenses$424K-3.9%$455K+21.0%$440K+43.3%$452K+3.0%$441K+6.5%$376K-9.6%$307K-34.3%$439K-0.6%
SG&A Expenses$8.4M+4.8%$6.2M-9.9%$6.8M+32.8%$9.7M+9.8%$8.0M+5.2%$6.9M+24.0%$5.1M+5.4%$8.8M-5.3%
Interest Expense$3K-57.1%$4K-33.3%$1K-87.5%$5K-53.9%$7K-22.2%$6K-40.0%$8K-83.3%$10K+9.5%
Income Tax$492K-51.1%$903K+18.5%$1.0M-19.0%$90K-68.5%$1.0M-45.6%$762K-44.2%$1.2M-25.2%$285K-61.6%
Net Income$1.6M-34.5%$2.1M+4.7%$2.3M-27.8%$729K-12.2%$2.5M+33.9%$2.0M-47.8%$3.1M-23.6%$830K-32.9%
EPS (Basic)$0.24-35.1%$0.30+7.1%$0.33-34.0%$0.11-15.4%$0.37+37.0%$0.28-51.7%$0.50-21.9%$0.13-27.8%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Operating Income, EBITDA, EPS (Diluted), Diluted Shares (Avg).

FONR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FONR quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$219.2M+2.0%$217.2M+4.5%$218.4M+2.9%$216.9M+1.2%$214.9M+2.5%$208.0M+2.8%$212.3M+5.3%$214.2M+6.8%
Current Assets$148.0M+4.9%$143.7M+4.4%$143.7M+3.3%$144.7M+3.1%$141.1M+3.9%$137.6M+3.8%$139.1M+7.7%$140.3M+11.7%
Cash & Equivalents$53.6M-1.1%$53.0M-1.1%$54.3M+0.2%$56.3M0.0%$54.3M+0.5%$53.6M+0.7%$54.2M+4.8%$56.3M+9.9%
Short-Term Investments$122K-0.8%$121K0.0%$122K-10.3%$120K-11.8%$123K-8.2%$121K+266.7%$136K+312.1%$136K+315.0%
Inventory$2.8M+4.6%N/AN/A$2.8M+3.6%$2.7M$2.9MN/A$2.7M+5.7%
Accounts Receivable$4.7M+2.6%$4.8M+40.3%$5.1M+32.9%$5.3M+31.5%$4.6M+38.9%$3.4M$3.9M$4.0M+4.5%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$4.3M0.0%$4.3M0.0%$4.3M0.0%$4.3M0.0%$4.3M0.0%$4.3M0.0%$4.3M0.0%$4.3M0.0%
Total Liabilities$54.8M+0.2%$54.4M+10.9%$57.0M+6.5%$56.8M-1.1%$54.7M+3.9%$49.0M+6.6%$53.5M+12.6%$57.5M+15.5%
Current Liabilities$16.1M+14.8%$14.4M+17.4%$16.7M+15.5%$17.1M-4.1%$14.0M-3.2%$12.2M-13.7%$14.4M+1.4%$17.9M+14.3%
Non-Current Liabilities$38.6M-4.9%$40.0M+8.8%$40.3M+3.2%$39.7M+0.2%$40.6M+6.6%$36.8M+15.7%$39.0M+17.4%$39.6M+16.0%
Long-Term DebtN/AN/AN/AN/AN/A$7K-92.4%$40K-61.5%$67K-41.8%
Total Equity$178.6M+3.9%$176.9M+4.2%$174.9M+3.7%$172.6M+4.0%$171.9M+3.7%$169.8M+3.6%$168.7M+4.6%$166.0M+5.1%
Retained Earnings$672K+111.2%-$969K+88.6%-$3.0M+71.2%-$5.3M+61.2%-$6.0M+58.4%-$8.5M+47.8%-$10.5M+47.8%-$13.6M+43.7%

FONR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FONR quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$1.6M-49.8%$171K-92.4%$1.7M+1.9%$4.2M-8.2%$3.1M+12.1%$2.2M-44.9%$1.7M-36.7%$4.6M+6.5%
Depreciation & AmortizationN/AN/AN/A$1.2M+10.7%$1.2M+9.5%$1.2M+1.2%$1.1M-11.0%$1.1M-11.2%
Capital Expenditures$171K-71.4%$398K-47.2%$1.9M+3.4%$647K+55.8%$598K+219.8%$754K+466.9%$1.8M+2765.1%$415K-37.6%
Free Cash Flow$1.4M-44.7%-$227K-115.3%-$177K-19.6%$3.6M-14.6%$2.5M-2.7%$1.5M-62.2%-$148K-105.8%$4.2M+14.5%
Investing Cash Flow-$173K+71.2%-$398K+46.1%-$2.4M-30.2%-$644K-84.2%-$600K-107.6%-$739K-455.6%-$1.8M-2201.3%-$350K+49.9%
Financing Cash Flow-$734K+60.8%-$1.1M+49.3%-$1.4M+30.5%-$1.5M+20.6%-$1.9M-6.3%-$2.1M+12.2%-$2.0M+6.5%-$1.9M+4.7%

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

FONR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

FONR quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Net Margin6.2%-3.0pp8.1%+0.2pp8.7%-3.9pp2.7%-0.5pp9.2%+1.9pp7.9%-6.9pp12.6%-3.3pp3.2%-1.6pp
Return on Equity0.9%-0.5pp1.2%0.0pp1.3%-0.6pp0.4%-0.1pp1.5%+0.3pp1.2%-1.1pp1.9%-0.7pp0.5%-0.3pp
Return on Assets0.8%-0.4pp0.9%0.0pp1.0%-0.4pp0.3%-0.1pp1.2%+0.3pp0.9%-0.9pp1.5%-0.6pp0.4%-0.2pp
Current Ratio9.18-0.9x10.00-1.2x8.63-1.0x8.45+0.6x10.05+0.7x11.24+1.9x9.64+0.6x7.86-0.2x
Debt-to-Equity0.310.0x0.31+0.3x0.33+0.3x0.33+0.3x0.32+0.3x0.000.0x0.000.0x0.000.0x
Asset Turnover0.120.0x0.120.0x0.120.0x0.130.0x0.130.0x0.120.0x0.120.0x0.120.0x
FCF Margin5.3%-4.1pp-0.9%-6.9pp-0.7%-0.1pp13.1%-3.0pp9.4%-0.8pp6.0%-9.5pp-0.6%-10.5pp16.1%+2.0pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Fonar Corporation FONR FY2025 $104.4M $8.3M 8.0% $120.2M 63/100
Burning Rock Biotech Limited BNR FY2025 $77.2M -$7.9M -10.3% $122.3M 60/100
Prenetics Global Limited PRE FY2025 $92.4M -$40.0M -43.3% $393.8M 40/100
MDxHealth SA MDXH FY2025 $107.9M -$33.5M -31.1% $67.2M 29/100
Biodesix, Inc. BDSX FY2025 $88.5M -$35.3M -39.9% $289.1M 51/100
Exagen Inc. XGN FY2025 $66.6M -$20.0M -30.0% $178.1M 47/100

Frequently Asked Questions

What is Fonar Corporation's annual revenue?

Fonar Corporation (FONR) reported $104.4M in total revenue for fiscal year 2025. This represents a 1.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Fonar Corporation's revenue growing?

Fonar Corporation (FONR) revenue grew by 1.4% year-over-year, from $102.9M to $104.4M in fiscal year 2025.

Is Fonar Corporation profitable?

Yes, Fonar Corporation (FONR) reported a net income of $8.3M in fiscal year 2025, with a net profit margin of 8.0%.

Fonar Corporation (FONR) had a net profit margin of 8.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Fonar Corporation (FONR) has a return on equity of 4.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Fonar Corporation (FONR) generated $7.5M in free cash flow during fiscal year 2025. This represents a -43.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Fonar Corporation (FONR) generated $11.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Fonar Corporation (FONR) had $216.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Fonar Corporation (FONR) invested $3.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Fonar Corporation (FONR) invested $1.6M in research and development during fiscal year 2025.

Yes, Fonar Corporation (FONR) spent $1.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Fonar Corporation (FONR) had a current ratio of 8.45 as of fiscal year 2025, which is generally considered healthy.

Fonar Corporation (FONR) had a debt-to-equity ratio of 0.33 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Fonar Corporation (FONR) had a return on assets of 3.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Fonar Corporation (FONR) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Fonar Corporation (FONR) has an earnings quality ratio of 1.35x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Fonar Corporation (FONR) scores 63 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top